Which laboratory test will be most beneficial in monitoring the effectiveness of drug therapy for hyperthyroidism?

• A. Free thyroxine (FT4)
• B. Free triiodothyronine (FT3)
• C. Triiodothyronine (T3), total
• D. Thyroxine (T4), total

Answer: (D)

The key idea is that monitoring hyperthyroidism treatment should reflect how much active thyroid hormone is circulating in the body. Thyroid hormones in the blood exist partly bound to proteins and partly unbound (the free portion). Only the free hormone is available to tissues and drives metabolic effects, so the test that best tracks treatment response is the free form of the hormone.

Free thyroxine (FT4) directly measures this unbound hormone, making it the most reliable indicator of whether therapy is bringing thyroid activity toward normal. Bound hormone levels can be influenced by factors that change binding proteins (like pregnancy, estrogen therapy, liver disease, or other conditions), which can make total hormone measurements misleading. Because total T4 or T3 can be skewed by these binding variations, they’re less dependable for guiding treatment. Monitoring FT4 provides a clearer picture of the body's current thyroid status and how well drug therapy is controlling hyperthyroidism.